Health Care Costs

  • |

    Congress Finds the Express Lane

    Washington can become very prayerful about procedure when families need lower costs, clear answers, or a little public relief. Suddenly every hallway is a wilderness, every calendar is a mystery, and every promise must be studied by a committee that meets somewhere behind the boiler room. But when congressional comfort, party power, or protected money needs shelter, brothers and sisters, the Red Sea develops an express lane.

    That is the moral audit here: ordinary people get the church-basement folding chair and a casserole labeled “thoughts,” while the powerful get the padded front pew and an usher with a stopwatch. If mercy ever receives the same urgency as self-protection, Congress may accidentally discover governing. Peace be with them, and may someone hide the loopholes where they keep the hymnals.

  • |

    The Patent Labyrinth: Why Cheaper Meds Are Stuck in Traffic

    Big Pharma’s favorite maze game? Patents. They claim innovation, yet leave generic drugs entangled in legal red tape longer than a DMV line on a Monday morning. It’s the classic bait-and-switch: promise a cure, deliver a price tag thicker than a lawyer’s billable hour.

    While pharmaceutical giants wax poetic about breakthrough treatments, what they really offer is a roadmap to higher costs. Consider it a toll booth nightmare where your wallet holds its breath as if it’s being drafted by your gym contractor. With every delay, there’s another bureaucratic hurdle—and we’re all just paying the fare for the privilege.

End of content

End of content